Using gene polymorphisms to assess bladder cancer risk: progress and challenges.

Using gene polymorphisms to assess bladder cancer risk: progress and challenges.

Show other versions (1)

Bibliographic Details
Main Author:	Kiltie, A
Format:	Journal article
Language:	English
Published:	2012

Similar Items

Using gene polymorphisms to assess bladder cancer risk: Progress and challenges
by: Kiltie, A
Published: (2012)

DNA repair gene XRCC1 polymorphisms and bladder cancer risk
by: Sak, S, et al.
Published: (2007)

Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
by: Sak, S, et al.
Published: (2006)

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.
by: Stern, M, et al.
Published: (2009)

Molecular epidemiology of DNA repair genes in bladder cancer.
by: Kiltie, A
Published: (2009)

DNA repair gene XPC polymorphisms, smoking, occupational exposures and the risk of bladder transitional cell carcinoma
by: Sak, S, et al.
Published: (2005)

The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
by: Teo, M, et al.
Published: (2012)

Common predisposition alleles for moderately common cancers: bladder cancer.
by: Kiltie, A
Published: (2010)

Gemcitabine as a Chemoradiosensitiser in Bladder Cancer
by: Kerr, M, et al.
Published: (2012)

Utility of bladder-sparing therapy vs radical cystectomy for muscle-invasive bladder cancer
by: Efstathiou, J, et al.
Published: (2018)

Predictive Biomarkers for Gemcitabine as a Chemoradiosensitizer in Bladder Cancer
by: Kerr, M, et al.
Published: (2012)

Analysis of variants in DNA damage signalling genes in bladder cancer
by: Choudhury, A, et al.
Published: (2008)

Association between interleukin-22 genetic polymorphisms and bladder cancer risk
by: Tao Zhao, et al.
Published: (2015-10-01)

Promoter hypermethylation identifies progression risk in bladder cancer.
by: Yates, DR, et al.
Published: (2007)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
by: Groselj, B, et al.
Published: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
by: Groselj, B, et al.
Published: (2013)

The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
by: Sak, S, et al.
Published: (2005)

Progress in bladder cancer research /
by: Mallory, A. M.
Published: (2005)

Renin-Angiotensin System Single Nucleotide Polymorphisms Are Associated with Bladder Cancer Risk
by: Maria Samara, et al.
Published: (2021-11-01)

Relationship of -31G/C (rs9904341) polymorphism in the survivin gene <i>BIRC5</i> and the risk of bladder cancer
by: E. E. Bashmakova, et al.
Published: (2022-09-01)

Assessment of acute bowel toxicity from chemoradiation for bladder cancer using an in vivo gastrointestinal crypt assay and in vitro organoid system
by: Gorrill, J, et al.
Published: (2017)

RAD51: A DNA repair target for increasing the therapeutic potential in bladder cancer
by: Choudhury, A, et al.
Published: (2005)

MNS16A VNTR polymorphic sequence variations of the TERT gene and bladder cancer: Correspondence
by: Rujittika Mungmunpuntipantip, et al.
Published: (2022-06-01)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation.
by: Marsh, H, et al.
Published: (2003)

Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer
by: Bei-Hao Shiu, et al.
Published: (2021-05-01)

In vitro functional effects of XPC gene rare variants from bladder cancer patients.
by: Qiao, B, et al.
Published: (2011)

Pioglitazone use and the risk of bladder cancer
by: Hsin-Wei Kuo, et al.
Published: (2014-02-01)

Polymorphisms in insulin pathway genes and cancer risk
by: Fatemeh Abedi Sarvestani, et al.
Published: (2022-12-01)

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
by: Ana Blanca, et al.
Published: (2023-04-01)

Genetic variants in telomere-maintenance genes and bladder cancer risk.
by: Joshua Chang, et al.
Published: (2012-01-01)

Imatinib radiosensitizes bladder cancer by targeting homologous recombination.
by: Qiao, B, et al.
Published: (2013)

Prostaglandin Synthase 2/Cyclooxygenase 2 Gene Polymorphisms and Susceptibility to Urothelial Bladder Cancer in an Iranian Population
by: Kamyar Mansori, et al.
Published: (2022-07-01)

Polymorphism of Folate metabolism genes and risk of lung cancer
by: M. L. Bakanova, et al.
Published: (2019-04-01)

Polymorphisms in inflammation pathway genes and endometrial cancer risk.
by: Delahanty, R, et al.
Published: (2013)

The role of cancer-associated fibroblasts in bladder cancer progression
by: Long Huang, et al.
Published: (2023-09-01)

Research progress on the microbiota in bladder cancer tumors
by: Keyuan Lou, et al.
Published: (2024-04-01)

Altered Glycosylation in Progression and Management of Bladder Cancer
by: Magdalena Wilczak, et al.
Published: (2023-04-01)

APE1 and XRCC1 protein expression levels predict cancer-specific survival following radical radiotherapy in bladder cancer.
by: Sak, S, et al.
Published: (2005)

The impact of histological variants of urothelial carcinoma on clinical outcomes following trimodality bladder-sparing chemoradiation
by: Kiltie, A, et al.
Published: (2017)

SIRT1 gene polymorphisms and risk of lung cancer
by: Lv Y, et al.
Published: (2017-09-01)